Clinical trials
Suspended Phase 2/3 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Suspended | 17 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Agennix | 1 |
| Arthritis Innovation Corporation | 1 |
| Hemosol | 1 |
| Jessica M D'Amico | 1 |
| Kibow Pharma | 1 |
| M.D. Anderson Cancer Center | 1 |
| MYnd Analytics | 1 |
| Mayo Clinic | 1 |
| NRG Oncology | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Agnosia | 1 |
| Alcoholism | 1 |
| Breast Carcinoma In Situ | 1 |
| Breast Neoplasms | 1 |
| COVID-19 | 1 |
| Carcinoma | 1 |
| Carcinoma, Intraductal, Noninfiltrating | 1 |
| Cardiovascular Diseases | 1 |
| Fractures, Stress | 1 |
| Oropharyngeal Neoplasms | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.